Hrishav Das Purkayastha,Ranjit Prasad Swain,Abhishek Bhattacharjee Hrishav Das Purkayastha

The review also reflects on the use of herbal extracts in combination with current therapies as a synergistic approach, particularly on the healing effects of such combinations and the need for solid clinical evidence to support such claims.

Arbor G Dykema,Ziga Vodusek,Ralina Karagenova et al. Arbor G Dykema et al.

Unfortunately, although many patients achieve an initial response with conventional immunosuppressant regimens, relapse is common, and current therapies are associated with damaging adverse effects and the risk of infection.

Sara Tavella,Alessia di Lillo,Anastasia Conti et al. Sara Tavella et al.

Indeed, an intrinsic challenge of most current therapies against cancer and viral infections is the non-specific toxicity that they can induce in normal tissues because of their impact on important cellular mechanisms shared, to different extents, between unhealthy and healthy cells.

M Tommy Gambles,Isaac Kendell,Jiahui Li et al. M Tommy Gambles et al.

This split antibody technology differs from current therapies by separating cancer cell-targeting components from T cell-engaging components.

Song Li,Yan-Ruide Li,Haochen Nan et al. Song Li et al.

Through its biomimetic design and localized immunostimulatory effects, iMRAS helps overcome the limitations of current therapies for solid tumors, establishing a robust platform for enhancing systemic CAR-iNKT cell-mediated immunotherapy.

Yixin Song,Kexin Zhang,Jingwen Zhang et al. Yixin Song et al.

It highlights current therapies targeting these epigenetic mechanisms, including gene editing, epigenetic drugs, and various other therapeutic approaches.

Jiahong Wu,Peng Wu,Sicheng Wang et al. Jiahong Wu et al.

Additionally, this review summarizes current therapies aimed at delaying aging, which may provide insights for future interventions targeting the aging of the reproductive system and other systems.

Rongyan He,Mingjuan Li,Weitao Li et al. Rongyan He et al.

Chronic neuropathic pain severely impairs quality of life, with current therapies often causing adverse effects. Our research group identified αO-conotoxin GeXIVA[1,2] as a potent analgesic candidate derived from marine cone snails.

Alice Sandberg-Janzon,Pontus Karling Alice Sandberg-Janzon

Conclusions: The overall 60-month drug survival for treatments prescribed in IBS is relatively low, suggesting that the effectiveness of current therapies remains limited.

Padmanabhan Anbazhagan,Jothi Anantharajan,Justina Fulwood et al. Padmanabhan Anbazhagan et al.

Among them, USP30 plays a pivotal role in mitochondrial quality control and has been implicated in idiopathic pulmonary fibrosis (IPF), a chronic lung disease for which current therapies merely slow disease progression.